K. Collins

发表

Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days

David T. Huang, C. Seymour, D. Angus, 2021, Contemporary Clinical Trials.

A Learning Health System Randomized Trial of Monoclonal Antibodies for Covid-19

C. Seymour, G. Snyder, D. Angus, 2021, medRxiv.

Effectiveness of casirivimab and imdevimab, and sotrovimab during Delta variant surge: a prospective cohort study and comparative effectiveness randomized trial

C. Seymour, G. Snyder, D. Angus, 2021, medRxiv.

The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial

David T. Huang, C. Seymour, D. Yealy, 2022, Contemporary Clinical Trials.

A Risk Stratification Approach to Allocating Diabetes Education and Support Services.

O. Marroquin, L. Siminerio, K. Collins, 2021, Diabetes technology & therapeutics.

Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19

David T. Huang, C. Seymour, D. Yealy, 2022, JAMA network open.

Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021

G. Snyder, L. Harrison, O. Marroquin, 2022, PloS one.

Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era

David T. Huang, D. Yealy, G. Snyder, 2022, Open forum infectious diseases.

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)

D. Angus, J. Luketich, M. Schwartz, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Association of subcutaneous or intravenous route of administration of casirivimab and imdevimab monoclonal antibodies with clinical outcomes in COVID-19.

David T. Huang, C. Seymour, D. Yealy, 2021, medRxiv.

Temporal Changes in Clinical Practice with COVID-19 Hospitalized Patients: Potential Explanations for Better In-Hospital Outcomes

D. Yealy, G. Snyder, J. Mellors, 2020, medRxiv.

Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study.

D. Angus, J. Luketich, M. Schwartz, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19

David T. Huang, C. Seymour, D. Yealy, 2023, Annals of Internal Medicine.

Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

David T. Huang, C. Seymour, D. Angus, 2021, Open forum infectious diseases.

Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge

David T. Huang, C. Seymour, D. Yealy, 2022, JAMA network open.

The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization

David T. Huang, C. Seymour, D. Angus, 2021, Trials.

Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19

David T. Huang, C. Seymour, D. Yealy, 2023, Annals of Internal Medicine.

Bacterial Vaginosis Treatment Patterns, Associated Complications, and Health Care Economic Burden of Women With Medicaid Coverage in the United States.

K. Tangirala, Jay Lin, K. Collins, 2023, The Annals of Pharmacotherapy.